Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pearson

Showing results (801-810 of 1,112) with videos related to

Pageof 112
Sort By:
American Heart Journal|August 2, 2003
Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary interventionJoseph B Muhlestein, Jeffrey L Anderson, Benjamin D Horne, et al.
Endocrinology, Diabetes & Metabolism|April 23, 2020
The impact of phenotype, ethnicity and genotype on progression of type 2 diabetes mellitusAnand Thakarakkattil Narayanan Nair, Louise A Donnelly, Adem Y Dawed, et al.
Annals of Human Genetics|February 22, 2005
Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpointsB D Horne, J L Anderson, J F Carlquist, et al.
Nature Medicine|December 8, 2022
Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster studyBeverley M Shields, Catherine D Angwin, Maggie H Shepherd, et al.
Cardiology|August 30, 2007
Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiographyMatthew T Rondina, Jason M Lappé, John F Carlquist, et al.
Journal of Molecular Biology|September 10, 2010
Structural insights into substrate specificity in variants of N-acetylneuraminic Acid lyase produced by directed evolutionIvan Campeotto, Amanda H Bolt, Thomas A Harman, et al.
Frontiers in Genetics|July 12, 2021
Polymorphism in <i>INSR</i> Locus Modifies Risk of Atrial Fibrillation in Patients on Thyroid Hormone Replacement TherapyEnrique Soto-Pedre, Moneeza K Siddiqui, Cyrielle Maroteau, et al.
Research in Veterinary Science|November 27, 2004
Naturally acquired attaching and effacing Escherichia coli in sheepA D Wales, G R Pearson, A Best, et al.
Diabetes|March 29, 2001
beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutationsE R Pearson, G Velho, P Clark, et al.
Addiction (Abingdon, England)|May 17, 2017
Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trialsKatie Witkiewitz, Matthew R Pearson, Kevin A Hallgren, et al.
Pageof 112

Showing results (801-810 of 1,112) with videos related to

Sort By:
Pageof 112
American Heart Journal|August 2, 2003
Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary interventionJoseph B Muhlestein, Jeffrey L Anderson, Benjamin D Horne, et al.
Endocrinology, Diabetes & Metabolism|April 23, 2020
The impact of phenotype, ethnicity and genotype on progression of type 2 diabetes mellitusAnand Thakarakkattil Narayanan Nair, Louise A Donnelly, Adem Y Dawed, et al.
Annals of Human Genetics|February 22, 2005
Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpointsB D Horne, J L Anderson, J F Carlquist, et al.
Nature Medicine|December 8, 2022
Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster studyBeverley M Shields, Catherine D Angwin, Maggie H Shepherd, et al.
Cardiology|August 30, 2007
Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiographyMatthew T Rondina, Jason M Lappé, John F Carlquist, et al.
Journal of Molecular Biology|September 10, 2010
Structural insights into substrate specificity in variants of N-acetylneuraminic Acid lyase produced by directed evolutionIvan Campeotto, Amanda H Bolt, Thomas A Harman, et al.
Frontiers in Genetics|July 12, 2021
Polymorphism in <i>INSR</i> Locus Modifies Risk of Atrial Fibrillation in Patients on Thyroid Hormone Replacement TherapyEnrique Soto-Pedre, Moneeza K Siddiqui, Cyrielle Maroteau, et al.
Research in Veterinary Science|November 27, 2004
Naturally acquired attaching and effacing Escherichia coli in sheepA D Wales, G R Pearson, A Best, et al.
Diabetes|March 29, 2001
beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutationsE R Pearson, G Velho, P Clark, et al.
Addiction (Abingdon, England)|May 17, 2017
Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trialsKatie Witkiewitz, Matthew R Pearson, Kevin A Hallgren, et al.
Pageof 112